Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chiglitazar”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Early research (Phase 1)Study completedNCT05681273
What this trial is testing

Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.

Who this might be right for
T2DM
Chipscreen Biosciences, Ltd. 48
Not applicableNot Yet RecruitingNCT07558525
What this trial is testing

Evaluation of Chiglitazar Sodium With Lifestyle Intervention for Reversing Prediabetes

Who this might be right for
Prediabetes
Second Xiangya Hospital of Central South University 472
Early research (Phase 1)Looking for participantsNCT06737523
What this trial is testing

Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML

Who this might be right for
Acute Myeloid LeukemiaRelapseRefractory AML
The First Affiliated Hospital of Xiamen University 30
Not applicableUnknownNCT06191328
What this trial is testing

A Prospective, Open, Self-controlled Study of the Effects of Chiglitazar Sodium on Glucose and Lipid Metabolism in Patients With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Diabetes
Yufan Wang 40
Large-scale testing (Phase 3)Study completedNCT04807348
What this trial is testing

Chiglitazar Added to Metformin for Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Chipscreen Biosciences, Ltd. 533
Testing effectiveness (Phase 2)Looking for participantsNCT07303803
What this trial is testing

Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus

Who this might be right for
MASH - Metabolic Dysfunction-Associated SteatohepatitisT2DM (Type 2 Diabetes Mellitus)
Shanghai Jiao Tong University School of Medicine 300
Not applicableUnknownNCT06007014
What this trial is testing

Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes

Who this might be right for
Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM PatientsMetformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect128 Patients Were Randomly Assigned 1:1+4 more
Yanbing Li 128
Large-scale testing (Phase 3)Study completedNCT02121717
What this trial is testing

Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Chipscreen Biosciences, Ltd. 535
Early research (Phase 1)Not Yet RecruitingNCT07511010
What this trial is testing

Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Chipscreen Biosciences, Ltd. 28
Large-scale testing (Phase 3)Study completedNCT06125587
What this trial is testing

Chiglitazar/Metformin in Non-obese Women With PCOS

Who this might be right for
Polycystic Ovary SyndromeChiglitazarMetformin
Shengjing Hospital 55
Early research (Phase 1)Study completedNCT05515445
What this trial is testing

Pharmacokinetics of Chiglitazar in Subjects With Hepatic Impairment and Normal Hepatic Function

Who this might be right for
Hepatic Impairment
Chipscreen Biosciences, Ltd. 24
Early research (Phase 1)Study completedNCT05515458
What this trial is testing

Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal Function

Who this might be right for
Renal Impairment
Chipscreen Biosciences, Ltd. 24
Large-scale testing (Phase 3)Study completedNCT02173457
What this trial is testing

Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Chipscreen Biosciences, Ltd. 740
Testing effectiveness (Phase 2)Looking for participantsNCT07783100
What this trial is testing

Venetoclax, Chidamide, and Chiglitazar Sodium (VCC) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia
The First Affiliated Hospital of Xiamen University 30
Testing effectiveness (Phase 2)Study completedNCT05193916
What this trial is testing

A Phase II Clinical Trial of Chiglitazar for NASH

Who this might be right for
NASH
Chipscreen Biosciences, Ltd. 104
Not applicableNot Yet RecruitingNCT06773221
What this trial is testing

The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver DiseaseCompensated Liver Cirrhosis
Beijing Friendship Hospital 195
Not applicableNot Yet RecruitingNCT07580638
What this trial is testing

Chiglitazar Added to SGLT-2 Inhibitors for Type 2 Diabetes

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Chipscreen Biosciences, Ltd. 3,550
Early research (Phase 1)UnknownNCT05760677
What this trial is testing

Study on the Efficacy and Safety of Chiglitazar Sodium in PCOS With T2DM

Who this might be right for
PCOS (Polycystic Ovary Syndrome) of Bilateral OvariesT2D
Affiliated Hospital of Nantong University 142
Not applicableStudy completedNCT07412015
What this trial is testing

Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Chipscreen Biosciences, Ltd. 24
Not applicableStudy completedNCT07519265
What this trial is testing

Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Chipscreen Biosciences, Ltd. 64
Next Page